These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22695620)

  • 1. The use of nanoparticles for gene therapy in the nervous system.
    Pérez-Martínez FC; Carrión B; Ceña V
    J Alzheimers Dis; 2012; 31(4):697-710. PubMed ID: 22695620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to non-viral vector-mediated gene delivery in the nervous system.
    Pérez-Martínez FC; Guerra J; Posadas I; Ceña V
    Pharm Res; 2011 Aug; 28(8):1843-58. PubMed ID: 21225319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral vectors for the delivery of small interfering RNAs to the CNS.
    Posadas I; Guerra FJ; Ceña V
    Nanomedicine (Lond); 2010 Oct; 5(8):1219-36. PubMed ID: 21039199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.
    Maitra A
    Expert Rev Mol Diagn; 2005 Nov; 5(6):893-905. PubMed ID: 16255631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides: important tools for the treatment of central nervous system disorders.
    Malavolta L; Cabral FR
    Neuropeptides; 2011 Oct; 45(5):309-16. PubMed ID: 21477861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrimers as vectors for genetic material delivery to the nervous system.
    Pérez-Martínez FC; Ocaña AV; Pérez-Carrión MD; Ceña V
    Curr Med Chem; 2012; 19(29):5101-8. PubMed ID: 22963638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chapter 1 - Drug delivery to the brain using colloidal carriers.
    Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
    Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non invasive gene therapy in neurological diseases].
    Brito-Armas JM; Castro-Hernandez J; Rodriguez-Diaz M; Castro-Fuentes R
    Rev Neurol; 2011 May; 52(10):603-17. PubMed ID: 21488008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle crossing of blood-brain barrier: a road to new therapeutic approaches to central nervous system diseases.
    Ceña V; Játiva P
    Nanomedicine (Lond); 2018 Jul; 13(13):1513-1516. PubMed ID: 29998779
    [No Abstract]   [Full Text] [Related]  

  • 10. [The blood-brain barrier is challenging drug development].
    Savolainen J; Mannila A
    Duodecim; 2005; 121(1):37-43. PubMed ID: 15712834
    [No Abstract]   [Full Text] [Related]  

  • 11. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of therapeutics to the central nervous system.
    Chambers JJ
    Adv Drug Deliv Rev; 2012 May; 64(7):589. PubMed ID: 22388004
    [No Abstract]   [Full Text] [Related]  

  • 13. Lentiviral vectors for use in the central nervous system.
    Jakobsson J; Lundberg C
    Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
    Andrieux K; Couvreur P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors in the brain and their potential clinical implications.
    Benarroch EE
    Neurology; 2012 Nov; 79(21):2148-53. PubMed ID: 23170013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL; Wu XY; Bendayan R
    Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents.
    Tosi G; Ruozi B; Belletti D; Vilella A; Zoli M; Vandelli MA; Forni F
    Nanomedicine (Lond); 2013 Sep; 8(9):1373-83. PubMed ID: 23565661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.